Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients.
about
A clinical guide to the management of genitourinary symptoms in breast cancer survivors on endocrine therapyAtrophic vaginitis in breast cancer survivors: a difficult survivorship issue.Gynecologic care for breast cancer survivors: assisting in the transition to wellnessVaginal Estrogen Therapy for Patients with Breast Cancer.Use of lactobacilli and estriol combination in the treatment of disturbed vaginal ecosystem: a review.Vaginal estrogen therapy in postmenopausal breast cancer patients treated with aromatase inhibitors.Oestrogens and overactive bladder.Management of menopause in women with breast cancer.Vaginal estrogen products in hormone receptor-positive breast cancer patients on aromatase inhibitor therapy.
P2860
Q33605919-1F1BBDF1-508A-49C7-902C-3C458E2ACA5DQ35824414-5C7FCE7E-A29C-4DB0-8AFF-D7248DFC03D8Q37119765-FFC133EA-4670-491E-A9B0-45D7723374D5Q37389691-85758615-259F-4041-A471-37346ED5730EQ37611334-B18CE19A-DA60-4CE2-8885-DB22382A3B09Q37972785-5D2B367C-B48A-46CF-9E94-7E6A99E94B44Q38122627-7B82BAD5-7145-479D-8023-608935366217Q38298951-B9592C7E-A62F-4429-AEB2-570ED9740380Q38834129-11A24C84-B5CA-4998-B4E1-E1D734A99675
P2860
Vaginal estriol to overcome side-effects of aromatase inhibitors in breast cancer patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Vaginal estriol to overcome si ...... ors in breast cancer patients.
@en
Vaginal estriol to overcome si ...... ors in breast cancer patients.
@nl
type
label
Vaginal estriol to overcome si ...... ors in breast cancer patients.
@en
Vaginal estriol to overcome si ...... ors in breast cancer patients.
@nl
prefLabel
Vaginal estriol to overcome si ...... ors in breast cancer patients.
@en
Vaginal estriol to overcome si ...... ors in breast cancer patients.
@nl
P2093
P2860
P1433
P1476
Vaginal estriol to overcome si ...... ors in breast cancer patients.
@en
P2093
A Fink-Retter
C F Singer
R Königsberg
T Geisendorfer
P2860
P304
P356
10.3109/13697137.2010.529967
P577
2011-01-13T00:00:00Z